Search Results - "Blumenreich, Aryeh"

Real world usage of gemcitabine and nabpaclitaxel in older adults with metastatic pancreatic cancer: A single institution experience by Winer, Arthur, Handorf, Elizabeth A., Nagappan, Lavanya, Blumenreich, Aryeh, Chowdhury, Farhana, Vijayvergia, Namrata, Dotan, Efrat

“…Abstract only 358 Background: The median age at diagnosis for metastatic pancreatic cancer (mPC) is 72. Gemcitabine and Nab-Paclitaxel (GA) is often the…”
Get full text

VTE among pancreatic cancer and its possible risk factors among metastatic pancreatic cancer (mPC): Experience at Fox Chase Cancer Center by Pandey, Ramesh Kumar, Sorice, Kristen, Gou, Jiangtao, Lynch, Shannon M., Blumenreich, Aryeh, Cheema, Khadija, Nagappan, Lavanya, Dotan, Efrat, Vijayvergia, Namrata

“…Abstract only 232 Background: The incidence of VTE is relatively high among mPC pts, upto 57%. It is associated with higher health care burden and mortality…”
Get full text

Neoadjuvant therapy (NAT) and its role for pancreatic adenocarcinoma (PC) in the current era: Institutional experience by Walzer, Emily, Deng, Mengying, Handorf, Elizabeth A., Blumenreich, Aryeh, Pease, Lauren, Dorta, Marianna, Sorice, Kristen, Lynch, Shannon M., Vijayvergia, Namrata, Dotan, Efrat

“…Abstract only 672 Background: PC affects 57,000 people in the U.S. annually with poor long-term outcomes. NAT for localized disease has increasingly been used…”
Get full text

Venous thromboembolism in metastatic pancreatic cancer by Laderman, Lauren, Sreekrishnanilayam, Krishnalatha, Pandey, Ramesh K., Handorf, Elizabeth, Blumenreich, Aryeh, Sorice, Kristen A., Lynch, Shannon M., Cheema, Khadija, Nagappan, Lavanya, Sosa, Iberia R., Dotan, Efrat, Vijayvergia, Namrata

“…Background Pancreatic cancer (PC) carries a high risk of venous thromboembolism (VTE). Several risk assessment models (RAMs) predict benefit of…”
Get full text